Which company's drug is neratinib (neratinib)? How much?

Neratinib (neratinib) is an oral drug that specifically inhibits human epidermal growth factor receptor tyrosine kinase. It can form irreversible binding to HER1, HER2 and HER4 receptors. This drug has been widely recognized and used in the adjuvant extended treatment of patients with early-stage breast cancer, as well as in adult patients with advanced or metastatic breast cancer. Clinical data have fully demonstrated the high efficacy and good safety record of neratinib, so it has become the focus of the current medical community. Next, we’ll dive into the development of this drug and its current pricing in the market.

Neratinib is a drug developed and produced byPuma Biotechnology, Inc. As an efficient and safe breast cancer treatment drug, the market price of neratinib is relatively high. That doesn't mean it's unreasonably priced, though. After all, drug research and development requires a large investment of money and time, and the excellent efficacy of neratinib is one of the important reasons for its high price. At present, the drug has been approved by the China Food and Drug Administration and is officially sold in pharmacies in my country, and patients can purchase and use it with medical advice. It is reported that a box of neratinib (neratinib) original drug sells for about six to seven thousand yuan. This market price may vary due to different pharmacies. But generally speaking, their prices generally range from several thousand yuan to ten thousand yuan. In addition, the drug has been successfully included in medical insurance, and patients can enjoy reimbursement discounts. The specific reimbursement policies vary depending on the region. Please consult the local medical insurance bureau for detailed information.

In addition, a generic version of neratinib (neratinib) has been launched in Bangladesh. The version produced by Yaopin International costs more than 3,000 yuan per box, which is much cheaper than the original drug. For patients with greater financial pressure, purchasing drugs overseas may be a good choice. However, there are risks when purchasing drugs overseas. You should choose formal channels to purchase drugs to ensure the quality and efficacy of the drugs.

In short, neratinib, asa masterpiece of Puma Biotechnology, Inc., has demonstrated excellent efficacy and safety in the field of breast cancer treatment. Although its market price is high, thanks to medical insurance policies and the emergence of generic drugs, patients will have more opportunities to receive treatment with this drug.